Phathom Pharmaceuticals : Material Event – Form 8-K
8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d)
Read more8-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, DC 20549 FORM 8-K CURRENT REPORT Pursuant to Section 13 or 15(d)
Read moreItem 8.01 Other Events. On May 25, 2022, Phathom Pharmaceuticals, Inc. (“Phathom” or the “Company”), announced that its new drug
Read morePosted May 22, 2022, 6:47 am Michael Ollove Stateline Last year, conservative Republicans in the Missouri legislature took a run
Read moreDr. Chris Nonhof, assistant professor of education and English at Northwestern College, has been named the 2022 recipient of the
Read moreThe following information should be read in conjunction with the interim condensed consolidated financial statements and related notes, included elsewhere
Read moreItem 1.01 Entry into a Material Definitive Agreement. Revenue Interest Financing Agreement On May 3, 2022, Phathom Pharmaceuticals, Inc. (the
Read moreVGI Health Technology Limited ABN: 35 111 082 485 Address: Level 45, MLC Centre, 19 Martin Place, Sydney NSW 2000
Read more2022 Proxy Statement 9900 Bren Road East Minnetonka, Minnesota 55343 April 22, 2022 Dear Fellow Shareholders: UnitedHealth Group is starting
Read moreGarmin and Twin Health Help Patients Monitor Diabetes April 22, 2022 Garmin wearables help countless people monitor their health –
Read moreTOKYO – Kirin Holdings Company, Limited’s (Kirin Holdings) received the 2022 ‘Technology Award for Agricultural Chemistry’ for the development and
Read more